Top French court confirms enforcer’s jurisdiction in abuse case
France’s top court has rejected Johnson & Johnson’s attempt to overturn a ruling that upheld the national competition authority’s decision to sanction the drugmaker’s subsidiary for delaying the entry of generic versions of a cancer treatment medication.
To read more
Subscribe to Global Competition Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.